🇺🇸 Converthera NAD plus Patch in United States

Converthera NAD plus Patch (NAD+) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Converthera NAD plus Patch in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Gastroenterology approved in United States

Frequently asked questions

Is Converthera NAD plus Patch approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Converthera NAD plus Patch in United States?

Through Medical INC. is the originator. The local marketing authorisation holder may differ — check the official source linked above.